The most elusive doping approach in elite athletes
Transfusion of one’s own blood to enhance physical performance, also known as autologous blood doping, is infamously hard to identify. Unlike the use of EPO, there are no easily detectable markers, making this transfusion a pressing issue for many sporting organizations (i.e. IAAF) and the global World Anti-Doping Agency (WADA). Transfusion of one’s own blood raises the oxygen-carrying capacity of the athlete’s blood. This increased capacity allows the athlete to get more oxygen to the muscles and can thereby compete harder and recover faster during rest periods.
Pro Test Diagnostics is developing a complementary test to monitor and detect illegal use of one’s own stored blood to enhance performance in elite athletes. The test used today focuses on the concentration of hemoglobin in blood, which can easily be manipulated to deceive the current test.
A real unmet need for a test that can reveal blood doping
The amount of money involved in worldwide sport championships is a staggering multi-billion dollar industry. In comparison, the IOC reported that US$350 million is spent on analysis and monitoring of athletes globally each year. While many unique and efficient tests for steroids, hormones and drugs are available, there is a great need for an accurate effective test to identify blood doping using one’s own blood.
In 2016, WADA laboratories conducted about 300 000 tests for doping and approximately 40 percent of these came from sports where it is advantageous to use blood doping. That makes a total market of approximately 100,000 tests. Between the years 2008-2016 not a single athlete was suspended for autologous blood doping, which reflects the lack of effieciency and rigor in existing tests.
Our solution – a unique, accurate test that can’t be tricked
Pro Test Diagnostics’ ABT™-test can expose athletes who have transfused their own stored blood. The test complements the workflow established by WADA for the blood monitoring module of an athlete’s biological passport – an established global monitoring document required by WADA. Pro Test Diagnostics will offer a complete single-use test kit, complete with the components to prepare samples and analyse the blood sample of an athlete.
Benefits for market introduction of the ABT™-test
The novel blood doping test offered by Pro Test Diagnostics complements the current workflow, enhances the sensitivity of the current process and is compatible with current instruments used at all anti-doping WADA-accredited laboratories. In addition we have;
- First-mover advantage and already established relationship with WADA, the main partner
- Outsourced manufacturing allows for lower internal infrastructure needs for product realization
Pro Test Diagnostics will manage the competition by introducing the first routine test and thereby become the golden standard for blood doping measurements. We will continue improvements of the product to maintain our leading position.
Current status and financing sought
Currently we have identified a specific combination of proteins and peptides to be used in the diagnostic kit. We are now entering into the kit production phase and we are therefore seeking a second investing partner for our venture. In addition, the company’s activity will include preparation for a full marketing effort to the IOC, WADA and sports organizations worldwide.
Pro Test Diagnostics is looking for a milestone driven investment package from an external investors to secure a successful market introduction globally. This includes continued participation of the present investor – Fort Knox Förvaltning – based in Umeå.